Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced it has been added ...

Wondering if LendingClub is still a smart buy after its big transformation into a digital bank, or if most of the upside is already priced in? This breakdown will help you make sense of where the real ...

From what we can see, insiders were net buyers in Cluey Ltd's (ASX:CLU ) during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it. While we would never ...

The latest narrative around Regions Financial has shifted as analysts trim their price target while nudging fair value higher to about $29.12 from roughly $28.45. This reflects a slightly more ...